Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 13NIH 7NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Prostatic Neoplasms 9Head and Neck Neoplasms 9Brain Neoplasms 6Uterine Cervical Neoplasms 4Tongue Neoplasms 4Central Nervous System Neoplasms 4Papillomavirus Infections 3Radiation Injuries 2Precancerous Conditions 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Endometrial Neoplasms 2Carcinoma 2Astrocytoma 2Anus Neoplasms 2Anal Canal Carcinoma 2Vulvar Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Obesity 1Neuroblastoma 1Neoplasms 1

Interventions

Radiotherapy 15Temozolomide 14Carmustine 6Lomustine 3Chemotherapy, Adjuvant 3Bevacizumab 3imetelstat 2Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2DNA Methylation 2vistusertib 1veliparib 1vatalanib 1temsirolimus 1sagopilone 1rubitecan 1palbociclib 1mercaptoundecahydrododecaborate 1marizomib 1lonafarnib 1fluciclovine F-18 1carmustine, poliferprosan 20 drug combination 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Re-Irradiation 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡